Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Short Interest Update

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 60,900 shares, a growth of 1,168.8% from the February 29th total of 4,800 shares. Based on an average daily volume of 2,262,900 shares, the short-interest ratio is currently 0.0 days.

Innovation Pharmaceuticals Stock Performance

IPIX opened at $0.01 on Thursday. The firm has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.01. Innovation Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.02.

About Innovation Pharmaceuticals

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.